Investigation of inpatient probiotic use at an academic medical center

Jacques Simkins-Cohen, Anna Kaltsas, Brian P. Currie

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objectives: Despite the widespread use of probiotics, there are limited data regarding their safety. The aims of this study were to characterize inpatient probiotic use and to determine the incidence of probiotic-related bloodstream infections due to Lactobacillus acidophilus/Lactobacillus bulgaricus. Methods: This study was a two-part retrospective study conducted at a large academic medical center. The first part was the characterization of probiotic use during 2007-2008, which included the type of prescribing provider, choice of probiotic prescribed, indications for use, and presence of potential risk factors for probiotic infection among recipients; the second part was the determination of the incidence of probiotic-related bloodstream infections due to L. acidophilus/L. bulgaricus for September 2000-August 2008. Results: Probiotic use was uncommon (0.4%). Ninety-six percent of patients received Lactobacillus-based compounds. Use was common in patients at theoretical risk for probiotic infection. The maximum estimated incidence of probiotic-related bacteremia due to L. acidophilus/L. bulgaricus during the 8-year period was 0.2%. Conclusions: L. acidophilus/L. bulgaricus probiotic use at our institution appeared to be associated with a minimal risk of probiotic-related infection, even though it was used at a high frequency among inpatients who could be considered at high theoretical risk for probiotic-related bloodstream infection.

Original languageEnglish
JournalInternational Journal of Infectious Diseases
Volume17
Issue number5
DOIs
StatePublished - May 1 2013
Externally publishedYes

Fingerprint

Probiotics
Inpatients
Lactobacillus delbrueckii
Lactobacillus acidophilus
Infection
Incidence
Lactobacillus
Bacteremia
Retrospective Studies

Keywords

  • Bloodstream infection
  • High risk patients
  • Lactobacillus
  • Probiotics
  • Safety

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Investigation of inpatient probiotic use at an academic medical center. / Simkins-Cohen, Jacques; Kaltsas, Anna; Currie, Brian P.

In: International Journal of Infectious Diseases, Vol. 17, No. 5, 01.05.2013.

Research output: Contribution to journalArticle

@article{236cad0ab3d141919c2c7f85ad6b8d70,
title = "Investigation of inpatient probiotic use at an academic medical center",
abstract = "Objectives: Despite the widespread use of probiotics, there are limited data regarding their safety. The aims of this study were to characterize inpatient probiotic use and to determine the incidence of probiotic-related bloodstream infections due to Lactobacillus acidophilus/Lactobacillus bulgaricus. Methods: This study was a two-part retrospective study conducted at a large academic medical center. The first part was the characterization of probiotic use during 2007-2008, which included the type of prescribing provider, choice of probiotic prescribed, indications for use, and presence of potential risk factors for probiotic infection among recipients; the second part was the determination of the incidence of probiotic-related bloodstream infections due to L. acidophilus/L. bulgaricus for September 2000-August 2008. Results: Probiotic use was uncommon (0.4{\%}). Ninety-six percent of patients received Lactobacillus-based compounds. Use was common in patients at theoretical risk for probiotic infection. The maximum estimated incidence of probiotic-related bacteremia due to L. acidophilus/L. bulgaricus during the 8-year period was 0.2{\%}. Conclusions: L. acidophilus/L. bulgaricus probiotic use at our institution appeared to be associated with a minimal risk of probiotic-related infection, even though it was used at a high frequency among inpatients who could be considered at high theoretical risk for probiotic-related bloodstream infection.",
keywords = "Bloodstream infection, High risk patients, Lactobacillus, Probiotics, Safety",
author = "Jacques Simkins-Cohen and Anna Kaltsas and Currie, {Brian P.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1016/j.ijid.2012.11.010",
language = "English",
volume = "17",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Investigation of inpatient probiotic use at an academic medical center

AU - Simkins-Cohen, Jacques

AU - Kaltsas, Anna

AU - Currie, Brian P.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Objectives: Despite the widespread use of probiotics, there are limited data regarding their safety. The aims of this study were to characterize inpatient probiotic use and to determine the incidence of probiotic-related bloodstream infections due to Lactobacillus acidophilus/Lactobacillus bulgaricus. Methods: This study was a two-part retrospective study conducted at a large academic medical center. The first part was the characterization of probiotic use during 2007-2008, which included the type of prescribing provider, choice of probiotic prescribed, indications for use, and presence of potential risk factors for probiotic infection among recipients; the second part was the determination of the incidence of probiotic-related bloodstream infections due to L. acidophilus/L. bulgaricus for September 2000-August 2008. Results: Probiotic use was uncommon (0.4%). Ninety-six percent of patients received Lactobacillus-based compounds. Use was common in patients at theoretical risk for probiotic infection. The maximum estimated incidence of probiotic-related bacteremia due to L. acidophilus/L. bulgaricus during the 8-year period was 0.2%. Conclusions: L. acidophilus/L. bulgaricus probiotic use at our institution appeared to be associated with a minimal risk of probiotic-related infection, even though it was used at a high frequency among inpatients who could be considered at high theoretical risk for probiotic-related bloodstream infection.

AB - Objectives: Despite the widespread use of probiotics, there are limited data regarding their safety. The aims of this study were to characterize inpatient probiotic use and to determine the incidence of probiotic-related bloodstream infections due to Lactobacillus acidophilus/Lactobacillus bulgaricus. Methods: This study was a two-part retrospective study conducted at a large academic medical center. The first part was the characterization of probiotic use during 2007-2008, which included the type of prescribing provider, choice of probiotic prescribed, indications for use, and presence of potential risk factors for probiotic infection among recipients; the second part was the determination of the incidence of probiotic-related bloodstream infections due to L. acidophilus/L. bulgaricus for September 2000-August 2008. Results: Probiotic use was uncommon (0.4%). Ninety-six percent of patients received Lactobacillus-based compounds. Use was common in patients at theoretical risk for probiotic infection. The maximum estimated incidence of probiotic-related bacteremia due to L. acidophilus/L. bulgaricus during the 8-year period was 0.2%. Conclusions: L. acidophilus/L. bulgaricus probiotic use at our institution appeared to be associated with a minimal risk of probiotic-related infection, even though it was used at a high frequency among inpatients who could be considered at high theoretical risk for probiotic-related bloodstream infection.

KW - Bloodstream infection

KW - High risk patients

KW - Lactobacillus

KW - Probiotics

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=84876078328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876078328&partnerID=8YFLogxK

U2 - 10.1016/j.ijid.2012.11.010

DO - 10.1016/j.ijid.2012.11.010

M3 - Article

VL - 17

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

IS - 5

ER -